Filter
683
Text search:
hiv
drug
resistance
Featured
Recommendations
69
New Publications
168
Language
Document type
No document type
431
Studies & Reports
88
Guidelines
82
Manuals
24
Strategic & Response Plan
24
Fact sheets
14
Training Material
13
Situation Updates
5
Infographics
1
Videos
1
Countries / Regions
India
32
South Africa
24
Western and Central Europe
24
Kenya
19
Eastern Europe
17
Ethiopia
13
Tanzania
12
Rwanda
12
Uganda
10
Zambia
10
Malawi
10
Global
10
Bangladesh
9
Sierra Leone
8
Nigeria
8
Ghana
8
Nepal
8
Africa
8
Philippines
7
Asia
7
Russia
7
Cambodia
6
Namibia
6
South–East Asia Region
6
Latin America and the Carribbean
6
Liberia
5
Ukraine
5
Lesotho
5
Myanmar / Burma
5
Cameroon
4
Venezuela
3
Senegal
2
Zimbabwe
2
Thailand
2
Indonesia
2
Papua New Guinea
2
Benin
2
Eswatini/ Swaziland
2
Botswana
2
West and Central Africa
2
Bhutan
2
Albania
2
Tajikistan
2
Georgia
2
Guinea
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Somalia
1
Pakistan
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Syria
1
China
1
Mozambique
1
Argentina
1
North Macedonia
1
Colombia
1
Ecuador
1
Sri Lanka
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Estonia
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
229
Clinical Guidelines
80
Women & Child Health
22
Key Resources
18
Public Health
16
Pharmacy & Technologies
8
Capacity Building
7
Annual Report MEDBOX
1
Toolboxes
TB
178
HIV
126
AMR
58
NTDs
19
Mental Health
18
Caregiver
16
Pharmacy
14
Refugee
10
COVID-19
8
Rapid Response
7
Planetary Health
7
Polio
6
Global Health Education
6
Ebola & Marburg
5
Malaria
5
NCDs
4
Disability
3
Conflict
3
Natural Hazards
3
Health Financing Toolbox
3
2.0 Rapid Response
2
Cholera
1
Zika
1
Specific Hazards
1
Social Ethics
1
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
HIV & AIDS Treatment in Practice No.202
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key inte
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug
...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and afford
...
This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has ado
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop
...